immunoforge Venture Capital
4 known investors
ImmunoForge is a South Korean drug development company that builds a pipeline of therapeutics based on its ELP (elastin-like polypeptide) half-life extension platform and a blood-brain-barrier shuttle platform (LMT15). Its programs include candidates for chronic myelogenous leukemia (KF1601) and Duchenne muscular dystrophy cardiomyopathy (Pemziviptadil).
BiotechDeep Tech
Founders & leadership
SA
Sungmin AhnCo-CEO
GJ
Giho JangCo-CEO
Investors · 4
Frequently asked questions
- What does immunoforge Venture Capital do?
- ImmunoForge is a South Korean drug development company that builds a pipeline of therapeutics based on its ELP (elastin-like polypeptide) half-life extension platform and a blood-brain-barrier shuttle platform (LMT15). Its programs include candidates for chronic myelogenous leukemia (KF1601) and Duchenne muscular dystrophy cardiomyopathy (Pemziviptadil).
- Who are immunoforge Venture Capital's investors?
- immunoforge Venture Capital's investors include Aju IB Invesment Corporation, IMM Investment Japan, Kiwoom Investment, We Ventures.